google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiykf7x3PGEAxUxmIkEHawQAp8QFnoFCIoBEAE&url=https%3A%2F%2Fassets.ctfassets.net%2Fsyq3snmxclc9%2F2mVob3c1aDd8CNvVnyei6n%2F95af7dbfd2958d4c2b8494048b4889b5%2FJAG_Docs_pt1_Og_WATERMARK_OVER_Redacted.pdf&usg=AOvVaw2FxEo9BX_QE_oWUQWycMYe&opi=89978449
DARPA Awards $22M for ‘Smart’ Device that Regenerates Muscle – Regenerative Medicine at the McGowan Institute
A multi-institution research team led by the University of Pittsburgh secured a $22 million grant from the Defense Advanced Research Projects Agency (DARPA) to develop a device combining artificial intelligence, bioelectronics and regenerative medicine to regrow muscle tissue, especially after combat injuries. McGowan Institute for Regenerative Medicine affiliated
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiykf7x3PGEAxUxmIkEHawQAp8QFnoFCOEBEAE&url=https%3A%2F%2Fwww.rand.org%2Fcontent%2Fdam%2Frand%2Fpubs%2Fresearch_reports%2FRR2900%2FRR2996%2FRAND_RR2996.pdf&usg=AOvVaw0ma-Fet4BrX79H0x3OwnyF&opi=89978449
TK (Takashi D. Yoshida) Kozai
Reliable Neural-Interface Technology
Defense Advanced Research Projects Agency Program Detail
Reliable Neural-Interface Technology (RE-NET) - Reliable Peripheral Interfaces
Defense Advanced Research Projects Agency Program Detail
Reliable Neural-Interface Technology (RE-NET) - Reliable Central-Nervous-System Interfaces
Defense Advanced Research Projects Agency Program Detail
City Council Affirms Support for Decriminalization of Entheogens - Seattle City Council Blog
Seattle, WA — Councilmember Andrew J. Lewis (District 7 – Pioneer Square to Magnolia) expressed enthusiasm following the passage of Resolution 32021, declaring that the investigation, arrest, and prosecution of anyone engaging in entheogen-related activities should be among Seattle’s lowest law enforcement priorities. Entheogens, commonly known psychedelics, have been shown to benefit the well-being of individuals suffering from depression,...
SEATTLE CITY COUNCIL - Record No: Res 32021
Title: A RESOLUTION declaring that the investigation, arrest, and prosecution of anyone engaging in entheogen-related activities should be among The City of Seattle’s lowest law enforcement priorities and stating the Council’s support for full decriminalization of these activities.
Without Veil, Nor Self | Entheogen
6 track album
Be Here Now - Google Books
Beloved guru Ram Dass tells the story of his spiritual awakening and gives you the tools to take control of your life in this “counterculture bible” (The New York Times) featuring powerful guidance on yoga, meditation, and finding your true self.When Be Here Now was first published in 1971, it filled a deep spiritual emptiness, launched the ongoing mindfulness revolution, and established Ram Dass as perhaps the preeminent seeker of the twentieth century.Just ten years earlier, he was known as Professor Richard Alpert. He held appointments in four departments at Harvard University. He published books, drove a Mercedes and regularly vacationed in the Caribbean. By most societal standards, he had achieved great success. . . . And yet he couldn’t escape the feeling that something was missing. Psilocybin and LSD changed that. During a period of experimentation, Alpert peeled away each layer of his identity, disassociating from himself as a professor, a social cosmopolite, and lastly, as a physical being. Fear turned into exaltation upon the realization that at his truest, he was just his inner-self: a luminous being that he could trust indefinitely and love infinitely.And thus, a spiritual journey commenced. Alpert headed to India where his guru renamed him Baba Ram Dass—“servant of God.” He was introduced to mindful breathing exercises, hatha yoga, and Eastern philosophy. If he found himself reminiscing or planning, he was reminded to “Be Here Now.” He started upon the path of enlightenment, and has been journeying along it ever since.Be Here Now is a vehicle for sharing the true message, and a guide to self-determination.
Entheogens (Psychedelic Drugs) and the Ancient Mystery Religions - ScienceDirect
The Mystery Religions of the ancient world frequently, if not always, employed the use of psychoactive drugs or entheogens to induce altered states of…
kappa-opioid receptor salvinorin a - Google Search
dynorphins - Google Search
Neurocognitive and neuroinflammatory correlates of PDYN and OPRK1 mRNA expression in the anterior cingulate in postmortem brain of HIV-infected subjects | Journal of Neuroinflammation | Full Text
Chronic inflammation may contribute to neuropsychological impairments in individuals with HIV, and modulation of this inflammatory response by opiate receptor ligands is important in light of the prevalence of drug use in HIV populations. Exogenous MOR and KOR agonists have differential effects on central nervous system (CNS) immunity and, while some data suggest KOR agonists are immunosuppressive, the KOR agonist dynorphin has been shown to stimulate human monocyte chemotaxis. In this study, we examined mRNA levels of endogenous opioid receptors OPRK1 and OPRM1, prodynorphin (PDYN), macrophage scavenger receptor CD163, and microglia/macrophage marker CD68 in the caudate and anterior cingulate of postmortem brains from HIV-positive and HIV-negative subjects. Brain tissues of HIV-infected (n = 24) and control subjects (n = 15) were obtained from the Manhattan HIV Brain Bank. Quantification of the gene mRNA was performed using SYBR Green RT-PCR. CD68 and CD163 were increased in HIV-positive (HIV+) compared to HIV-negative (HIV-) individuals in both brain regions. There were higher OPRK1 (P
Frontiers | Morphological Changes of Frontal Areas in Male Individuals With HIV: A Deformation-Based Morphometry Analysis
ObjectivePrevious studies on HIV-infected (HIV+) individuals have revealed brain structural alterations underlying HIV-associated neur...
local HIV-induced striatal pathology - Google Search
cingulate - Google Search
CTx-1301 - Google Search
Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD - Cingulate Inc
Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and Duration KANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform
Study Details | Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. | ClinicalTrials.gov
Federal Research Experience | Rho
Our research teams are motivated by discovery and results. You can have confidence in our low-risk, rapid and agile study conduct and end-to-end services.
Rho, Inc. - Google Search
COVID-19 - New and Ongoing Development Programs & Trials | Rho
We are committed to helping our clients continue development and navigate this complex research landscape safely, including decentralized clinical trials.
Content Library: Our Blog | Discover What Drives Rho
Explore our content library to locate valuable resources from our team of global experts. Gain insights from our curated blog posts.
Patient-Centric Decentralized Solution for a Dermatology Trial | Rho
This case study demonstrates a number of tailored solutions for designing and executing successful decentralized solutions during COVID-19.
Case Study Outlines Rho's Successful Initiatives During COVID-19 | Rho
ISS & ISE Services, Integrated Analysis Development | Rho
Our team provides integrated clinical databases that are accurate, complete, and allow for a full assessment of the risk-benefit profile of your program.
Regulatory Agency Meetings | Rho
Our experts are prepared to handle a variety of global regulatory and advisory agencies, reducing time to market and conserving patent life.
Additional Global Therapeutic Experience | Rho
Our commitment to improve health, extend life, and enhance quality of life worldwide has led us to a wealth of clinical experience. This is what drives us.